Tinostamustine Active Not Recruiting Phase 1 Trials for Multiple Myeloma (MM) / Cutaneous T-Cell Lymphoma (CTCL) / Hematological Malignancy / Hodgkin's Lymphoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02576496Study of Tinostamustine, First-in-Class Alkylating HDACi Fusion Molecule, in Relapsed/Refractory Hematologic Malignancies